Merck & Co., Inc. (NYSE: MRK), Springfield, NJ – FDA Inspections

Inspection records and compliance data for Merck & Co., Inc. in Springfield, New Jersey. 3 FDA inspections on record, last inspected February 29, 2012. Publicly traded as NYSE: MRK.

Company Profile

This profile covers Merck & Co., Inc. based in Springfield, New Jersey, United States.

FDA Inspection History

FDA inspections: 3
OAI: 0
VAI: 3
NAI: 0
Form 483s: 0
Warning letters: 0

First inspected October 23, 2009. Last inspected February 29, 2012.

Most cited issue areas

General responsibilities of sponsors3 inspections
New observations, adverse effects and risks1 inspection

FDA inspections (3)

Date	Result	FDA center(s)	Insp. #
February 29, 2012	VAI	Human Drugs · Bioresearch Monitoring	769778
May 6, 2011	VAI	Human Drugs · Bioresearch Monitoring	723101
October 23, 2009	VAI	Human Drugs · Bioresearch Monitoring	625789

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Orgenus Pharma, Inc.

Pace Analytical Life Sciences, Inc.

Shua-Haim, Joshua R. MD

Bristol-Myers Squibb Company

Kett, Attila, M.D.-St Peters Univ Hosp - Dept. of Anesthesia

Helsinn Therapeautics Inc.

Propak Development, Inc.

Claris Lifesciences Inc

DSHealthcare Inc. dba Sultan Health Care

Cardinal Health 414 LLC